Prosecution Insights
Last updated: October 04, 2026

Gates & Cooper LLP (General)

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

48 pending office actions • 9 clients • 47 examiners • 32 art units • 0 of 48 (0%) have an AI response strategy ready

Analysis

GATES & COOPER LLP (General) has a track record in the Biotechnology & Pharmaceuticals technology area. The firm has managed a total of 34213 career applications, which is a high volume of work. This dataset of 34213 applications provides a view of their long-term prosecution trends. Currently, the firm has 34 pending office actions.

The firm's resolved allowance rate is 84.55 percent. To secure these allowances, the firm averages 3.82 office actions per allowance. This 3.82 average reflects the inherent complexity and examination standards of the Biotechnology & Pharmaceuticals sector. The 84.55 percent allowance rate indicates a level of success despite these challenges.

With 34 pending office actions, the firm continues its work in this field. The 34213 career applications demonstrate a depth of experience. Practitioners can use the 84.55 percent resolved allowance rate and the 3.82 average office actions per allowance to set expectations for the prosecution of complex biotech and pharmaceutical patents.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=34213 apps, methodology: how we score firms)

84.6%
Allowance Rate
n=34213
+0.65σ
Allowance Rate (norm)
n=34213
3.8
OAs to Allowance
n=20667
+0.03σ
OAs to Allow (norm)
n=20667
1082 days
Time to Allowance
n=20667
+8.9pp
Interview Lift
n=34213
32.5%
RCE Rate
n=34213
2.7%
Appeal Rate
n=34213

Rejection Performance (% of received rejections ultimately overcome)

76.2%
§101 Overcome
n=2437
77.2%
§102 Overcome
n=9011
77.9%
§103 Overcome
n=15242
77.9%
§112 Overcome
n=10440

Specialization & Scale

A61K, H01M, G06F
Top CPC Subclasses
13%
Top-3 CPC Share
n=34213
90
Practitioners
n=34213
380.1
Apps / Practitioner
n=34213

Portfolio Summary

48
Total Pending OAs
28
Non-Final OAs
18
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
1
Due this week
1
Due this month
1
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 7 days (1)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

26
Hard (54%)
20
Medium (42%)
2
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (4%)
§103 only13 (27%)
§102 only2 (4%)
§112 only1 (2%)
Double-patenting only1 (2%)
Double-patenting + other5 (10%)
Multi-statute (no §101)24 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

21
Life Sciences
44% of docket
2
Information Tech
4% of docket
0
Communications
0% of docket
12
Semiconductors
25% of docket
1
Mechanical / Eng
2% of docket
12
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

480 h
Manual time on pending OAs
96 h
Time saved (low, 20%)
168 h
Time saved (mid, 35%)
4.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YU, DAVID TUYANG 2 100.0% +0.0%
CHOY, PAN G 1 24.4% +34.9%
CHEN, CHIA-LING 1 51.3% +42.0%
HOLMES, REX R 1 80.2% +17.9%
SOHN, SEUNG C 1 87.1% +9.0%
LIPPERT, JOHN WILLIAM 1 58.2% +40.0%
HAUK TEODORO, PRICILA NMN 1 50.0% +0.0%
BARSKY, JARED 1 50.2% +22.7%
AHMED, MASHAL 1 — —
TRAN, LONG T 1 83.2% +13.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18254086 CRISPR RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS YU, DAVID TUYANG 71d
18819803 QUANTUM COHERENT RECEIVER SOHN, SEUNG C —

Hard Cases (26)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18532212 DECOMPOSABLE AND RECYCLABLE EPOXY THERMOSETTING RESINS MCCULLEY, MEGAN CASSANDRA 113d overdue
18175378 METHOD FOR GENERATION OF RANDOM QUANTUM STATES AND VERIFICATION OF QUANTUM DEVICES HALES, BRIAN J 30d overdue
18248740 METHOD OF TRANSFERRING A PATTERN TO AN EPITAXIAL LAYER OF A LIGHT EMITTING DEVICE QI, HUA 19d overdue
18476808 NOVEL COATING METHOD OF COMPLEX 3D STRUCTURES USING LOW PRESSURE CHEMICAL VAPOR DEPOSITION CHEN, KEATH T 28d
18290257 PRODUCTION OF ENGINEERED T CELLS FROM STEM CELLS VIVLEMORE, TRACY ANN 55d
18252605 DEVELOPMENT OF A NOVEL ELISA-BASED POINT-OF-CARE ANTIGEN TEST FOR SARS-COV-2 LUSI, ELLIS FOLLETT 75d
17912821 PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME CAIN, JENNIFER LYNN 79d
19245077 Swarm Based Orchard Management CHOY, PAN G —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
19245077 Swarm Based Orchard Management CHOY, PAN G —
18990696 RANGING WITH INTEGRATED OPTICAL PARAMETRIC OSCILLATORS CHEN, CHIA-LING —
18849414 BIOELECTRONIC SMART BANDAGE FOR CONTROLLING WOUND PH THROUGH PROTON DELIVERY HOLMES, REX R —
18841542 METHODS AND MATERIALS FOR IMAGING ADIPOSE TISSUE LIPPERT, JOHN WILLIAM —
18832236 NOVEL REGIMEN FOR AUGMENTING AND EXTENDING TRANSPLANT TOLERANCE BARSKY, JARED —
18752231 FIBER-SEISMIC TOMOGRAPHY TRAN, LONG T —

Client Portfolio (9 clients)

Top Art Units

Art UnitApps
28132
16382
16432
28982
36231
28781
16931
28451
17671
16711

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19245077 Swarm Based Orchard Management Bovi, Inc. CHOY, PAN G 3623 §101§103§112 Non-Final OA — Pending Jun 20, 2025
18990696 RANGING WITH INTEGRATED OPTICAL PARAMETRIC OSCILLATORS California Institute Of Technology CHEN, CHIA-LING §103 Non-Final OA — Pending Dec 20, 2024
18849414 BIOELECTRONIC SMART BANDAGE FOR CONTROLLING WOUND PH THROUGH PROTON DELIVERY The Regents of the University of California HOLMES, REX R §102§103 Non-Final OA — Pending Sep 20, 2024
18819803 QUANTUM COHERENT RECEIVER California Institute Of Technology SOHN, SEUNG C 2878 §102 Non-Final OA — Pending Aug 29, 2024
18841542 METHODS AND MATERIALS FOR IMAGING ADIPOSE TISSUE Cellsight Technologies Inc. LIPPERT, JOHN WILLIAM §103 Non-Final OA — Pending Aug 26, 2024
18836272 NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS The Regents of the University of California HAUK TEODORO, PRICILA NMN §103 Non-Final OA — Pending Aug 06, 2024
18832236 NOVEL REGIMEN FOR AUGMENTING AND EXTENDING TRANSPLANT TOLERANCE The Regents of the University of California BARSKY, JARED §102§103§112 Non-Final OA — Pending Jul 23, 2024
18730604 III-NITRIDE-BASED HIGH EFFICIENCY AND HIGH-POWER DEVICES GROWN ON OR ABOVE A STRAIN RELAXED TEMPLATE The Regents of the University of California AHMED, MASHAL §102§103Other Non-Final OA — Pending Jul 19, 2024
18752231 FIBER-SEISMIC TOMOGRAPHY California Institute Of Technology TRAN, LONG T §101§103§112 Non-Final OA — Pending Jun 24, 2024
18639864 WEARABLE BIOELECTRONICS FOR PROGRAMMABLE DELIVERY OF THERAPY The Regents of the University of California VOKES, KATHLEEN PAIGE §102§103§112 Non-Final OA — Pending Apr 18, 2024
18629732 QUANTUM PHASED ARRAYS California Institute Of Technology DINKE, BITEW A §102§103§112 Non-Final OA — Pending Apr 08, 2024
18292207 BARRIER FUNCTION PRESERVING PEPTIDES FOR MEMBRANES The Regents of the University of California HA, JULIE §102§103§112 Non-Final OA — Pending Jan 25, 2024
18579766 STRUCTURE-BASED DESIGN OF ANTISENSE OLIGONUCLEOTIDE DRUGS The Regents of the University of California YU, DAVID TUYANG 1693 §102§103§112 Non-Final OA — Pending Jan 16, 2024
18537495 ALL-INTEGRATED PHOTONIC TRANSCEIVER WITH A COMMON APERTURE California Institute Of Technology WOODS, BRANDON SEAN 2845 §103 Final Rejection — Pending Dec 12, 2023
18532212 DECOMPOSABLE AND RECYCLABLE EPOXY THERMOSETTING RESINS The Regents of the University of California MCCULLEY, MEGAN CASSANDRA 1767 §103§112 Final Rejection 113d overdue Pending Dec 07, 2023
18567162 III-V, II-VI IN-SITU COMPLIANT SUBSTRATE FORMATION The Regents of the University of California NICELY, JOSEPH C 2813 DP Final Rejection — Pending Dec 05, 2023
18560669 A PROCESSABLE, HIGH-PERFORMANCE DIELECTRIC ELASTOMER AND MULTILAYER DIELECTRIC ELASTOMER ACTUATOR The Regents of the University of California COPENHEAVER, BLAINE R §102§103§112 Non-Final OA — Pending Nov 13, 2023
18290259 ENGINEERING STEM CELLS FOR ALLOGENIC CAR T CELL THERAPIES The Regents of the University of California LY, KRISTINA ELISABETH 1671 §103§112Other Non-Final OA — Pending Nov 10, 2023
18290257 PRODUCTION OF ENGINEERED T CELLS FROM STEM CELLS The Regents of the University of California VIVLEMORE, TRACY ANN 1638 §102§103§112Other Non-Final OA 55d Pending Nov 10, 2023
18559983 COMB POLYELECTROLYTE STABILIZED COMPLEX COACERVATE EMULSIONS The Regents of the University of California SHELTON, SYNPHANE LA'SHAWN 1621 §103§112 Non-Final OA — Pending Nov 09, 2023
18559654 III-NITRIDE-BASED DEVICES GROWN ON A THIN TEMPLATE ON THERMALLY-DECOMPOSED MATERIAL The Regents of the University of California YECHURI, SITARAMARAO S §103 Non-Final OA — Pending Nov 08, 2023
18476808 NOVEL COATING METHOD OF COMPLEX 3D STRUCTURES USING LOW PRESSURE CHEMICAL VAPOR DEPOSITION California Institute Of Technology CHEN, KEATH T 1716 §103§112 Final Rejection 28d Pending Sep 28, 2023
18547752 METHOD TO IMPROVE THE PERFORMANCE OF GALLIUM-CONTAINING MICRON-SIZED LIGHT-EMITTING DEVICES The Regents of the University of California CRAWFORD EASON, LATANYA N 2813 §102§103 Non-Final OA — Pending Aug 24, 2023
18352403 HOT FORMING OF CURVED MIRRORS WITHOUT THE NEED FOR A MANDREL The Regents of the University of California DEAN, RAY ALEXANDER 2872 §103 Non-Final OA 37d overdue Pending Jul 14, 2023
18352175 EPITAXIAL SUBSTRATE SURFACES FOR SEMICONDUCTOR MATERIAL GROWTH AND IMPROVED SMOOTH SEMICONDUCTOR SURFACES FOR HIGHER CHANNEL MOBILITY THROUGH THE FORMATION AND REMOVAL OF REACTIVE LAYERS California Institute Of Technology WEGNER, AARON MICHAEL 2897 §102§103§112 Final Rejection — Pending Jul 13, 2023
18257548 RNA CONSTRUCT Vaxequity Ltd. WEHBE, ANNE MARIE SABRINA 1634 §102§112DP Non-Final OA — Pending Jun 14, 2023
18254086 CRISPR RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS The Regents of the University of California YU, DAVID TUYANG 1635 §102§103§112DPOther Non-Final OA 71d Pending May 23, 2023
18252605 DEVELOPMENT OF A NOVEL ELISA-BASED POINT-OF-CARE ANTIGEN TEST FOR SARS-COV-2 The Regents of the University of California LUSI, ELLIS FOLLETT 1677 §103§112 Non-Final OA 75d Pending May 11, 2023
18315370 MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING The Regents of the University of California BARRON, SEAN C 1798 §102§103§112 Non-Final OA — Pending May 10, 2023
18249907 MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING TUMOR ASSOCIATED MACROPHAGES (TAMS) The Regents of the University of California SHUPE, ELIZABETH A 1643 §103§112DP Final Rejection — Pending Apr 20, 2023
18249663 MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING ANTITUMOR T CELL IMMUNITY The Regents of the University of California YOUNG, MICAH PAUL 1618 §102§103DP Final Rejection — Pending Apr 19, 2023
18299415 METHOD OF TREATING CANCER WITH A BRCA1-ASSOCIATED PROTEIN 1 INHIBITOR AND A DEATH RECEPTOR LIGAND UCL Business PLC DENT, ALANA HARRIS 1643 §103 Final Rejection — Pending Apr 12, 2023
18248817 NITRIDE BASED ULTRAVIOLET LIGHT EMITTING DIODE WITH AN ULTRAVIOLET TRANSPARENT CONTACT The Regents of the University of California SMITH, BRADLEY 2817 §103 Non-Final OA 6d Pending Apr 12, 2023
18248740 METHOD OF TRANSFERRING A PATTERN TO AN EPITAXIAL LAYER OF A LIGHT EMITTING DEVICE The Regents of the University of California QI, HUA 1714 §102§103§112 Final Rejection 19d overdue Pending Apr 12, 2023
18187419 TECHNIQUES FOR TRANSDUCTION AND STORAGE OF QUANTUM LEVEL SIGNALS California Institute Of Technology CHANG, JOSEPH 2849 §112 Final Rejection 38d overdue Pending Mar 21, 2023
18175378 METHOD FOR GENERATION OF RANDOM QUANTUM STATES AND VERIFICATION OF QUANTUM DEVICES California Institute Of Technology HALES, BRIAN J 2125 §103§112 Final Rejection 30d overdue Pending Feb 27, 2023
18005936 A CHEMICAL COCKTAIL DRIVING EXPANSION OF MYOGENIC STEM CELLS The Regents of the University of California AMICK, THOMAS RUSSE 1638 §103 Final Rejection — Pending Jan 18, 2023
18154498 Alpha-Ketobutyrate, 2-Hydroxybutyrate, and Alpha-Ketoglutarate for Stimulating Hair Growth The Regents of the University of California NEAGU, IRINA 1629 §102§103 Non-Final OA — Pending Jan 13, 2023
17968556 WAFER SCALE PRODUCTION OF SUPERCONDUCTING MAGNESIUM DIBORIDE THIN FILMS WITH HIGH TRANSITION TEMPERATURE California Institute Of Technology WARTALOWICZ, PAUL A 1735 §102§103 Final Rejection — Pending Oct 18, 2022
17918707 ROOM TEMPERATURE THREE DIMENSIONAL PRINTING OF A SUPER-SOFT AND SOLVENT FREE ELASTOMER The Regents of the University of California BLAND, ALICIA 1759 §102§103 Final Rejection — Pending Oct 13, 2022
17912821 PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME Orthogonal Thinker, Inc. CAIN, JENNIFER LYNN 1655 §102§103 Final Rejection 79d Pending Sep 19, 2022
17801612 GROUP III-N LIGHT EMITTER ELECTRICALLY INJECTED BY HOT CARRIERS FROM AUGER RECOMBINATION The Regents of the University of California VAN ROY, TOD THOMAS 2828 §103 Non-Final OA — Pending Aug 23, 2022
17772715 FORMATION OF MICROLED MESA STRUCTURES WITH ATOMIC LAYER DEPOSITION PASSIVATED SIDEWALLS, A SELF-ALIGNED DIELECTRIC VIA TO THE TOP ELECTRICAL CONTACT, AND A PLASMA-DAMAGE-FREE TOP CONTACT The Regents of the University of California MULERO FLORES, ERIC MANUEL 2898 §103 Non-Final OA — Pending Apr 28, 2022
17766960 METHOD OF FABRICATING A RESONANT CAVITY AND DISTRIBUTED BRAGG REFLECTOR MIRRORS FOR A VERTICAL CAVITY SURFACE EMITTING LASER ON A WING OF AN EPITAXIAL LATERAL OVERGROWTH REGION The Regents of the University of California NETTLES, CORALIE ANN 2893 §103 Non-Final OA 61d Pending Apr 06, 2022
17642057 METHOD FOR RELAXING SEMICONDUCTOR FILMS INCLUDING THE FABRICATION OF PSEUDO-SUBSTRATES AND FORMATION OF COMPOSITES ALLOWING THE ADDITION OF PREVIOUSLY UN-ACCESSIBLE FUNCTIONALITY OF GROUP lll-NITRIDES The Regents of the University of California PRIDEMORE, NATHAN ANDREW 2898 §102§103§112 Final Rejection — Pending Mar 10, 2022
17618240 ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF UNIVERSITY OF SOUTHERN CALIFORNIA ALSOMAIRY, SARAH ABDOALATIF 1646 §102 Final Rejection — Pending Dec 10, 2021
17509926 SCALABLE AND DISTRIBUTED MACHINE LEARNING FRAMEWORK WITH UNIFIED ENCODER (SULU) California Institute Of Technology KAPOOR, DEVAN 2126 §103 Final Rejection 89d overdue Pending Oct 25, 2021
17047522 Methods and Compositions for Hair Growth by Activating Autophagy The Regents of the University of California SONG, JIANFENG 1613 §103DP Non-Final OA — Pending Oct 14, 2020

Managing Gates & Cooper LLP (General)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month